Mcrae Capital Management Inc Eli Lilly & CO Transaction History

Mcrae Capital Management Inc

  • $486 Million
  • Q3 2024

A detailed history of Mcrae Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Mcrae Capital Management Inc holds 1,071 shares of LLY stock, worth $808,605. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,071
Previous 1,121 4.46%
Holding current value
$808,605
Previous $1.01 Million 6.51%
% of portfolio
0.19%
Previous 0.24%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$772.14 - $960.02 $38,607 - $48,001
-50 Reduced 4.46%
1,071 $948,000
Q1 2024

Apr 18, 2024
SELL
$592.2 - $792.28 $65,142 - $87,150
-110 Reduced 8.94%
1,121 $872,000
Q3 2023

Oct 17, 2023
SELL
$434.7 - $599.3 $71,725 - $98,884
-165 Reduced 11.82%
1,231 $661,000
Q2 2023

Jul 21, 2023
SELL
$350.74 - $468.98 $17,537 - $23,449
-50 Reduced 3.46%
1,396 $654,000
Q1 2023

Apr 19, 2023
SELL
$310.63 - $364.82 $59,019 - $69,315
-190 Reduced 11.61%
1,446 $496,000
Q4 2022

Jan 20, 2023
SELL
$321.55 - $374.67 $40,193 - $46,833
-125 Reduced 7.1%
1,636 $0
Q3 2022

Oct 20, 2022
SELL
$296.48 - $337.87 $250,229 - $285,162
-844 Reduced 32.4%
1,761 $569,000
Q2 2022

Jul 20, 2022
BUY
$278.73 - $327.27 $51,007 - $59,890
183 Added 7.56%
2,605 $845,000
Q4 2021

Jan 26, 2022
SELL
$224.85 - $279.04 $22,485 - $27,904
-100 Reduced 3.97%
2,422 $669,000
Q4 2020

Jan 27, 2021
BUY
$130.46 - $172.63 $13,046 - $17,263
100 Added 4.13%
2,522 $426,000
Q2 2020

Jul 23, 2020
SELL
$136.42 - $164.18 $5,729 - $6,895
-42 Reduced 1.7%
2,422 $398,000
Q1 2020

Apr 16, 2020
BUY
$119.05 - $147.35 $40,715 - $50,393
342 Added 16.12%
2,464 $342,000
Q3 2019

Oct 21, 2019
SELL
$106.79 - $116.16 $56,812 - $61,797
-532 Reduced 20.05%
2,122 $237,000
Q3 2018

Oct 15, 2018
SELL
$85.86 - $107.31 $8,586 - $10,731
-100 Reduced 3.63%
2,654 $285,000
Q4 2017

Feb 13, 2018
SELL
$81.94 - $87.89 $28,679 - $30,761
-350 Reduced 11.28%
2,754 $233,000
Q3 2017

Oct 23, 2017
BUY
$77.07 - $85.54 $239,225 - $265,516
3,104
3,104 $266,000

Others Institutions Holding LLY

# of Institutions
4,007
Shares Held
752M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mcrae Capital Management Inc Portfolio

Follow Mcrae Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcrae Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcrae Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email